Johnson & Johnson (BMV:JNJ)
3,825.00
-40.00 (-1.03%)
At close: Jan 20, 2026
Johnson & Johnson Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2017 - 2021 |
| 94,193 | 88,821 | 85,159 | 79,990 | 78,740 | Upgrade | |
Revenue Growth (YoY) | 6.05% | 4.30% | 6.46% | 1.59% | -4.66% | Upgrade |
Cost of Revenue | 30,256 | 27,036 | 26,044 | 24,596 | 23,402 | Upgrade |
Gross Profit | 63,937 | 61,785 | 59,115 | 55,394 | 55,338 | Upgrade |
Selling, General & Admin | 23,676 | 21,952 | 20,166 | 19,078 | 19,506 | Upgrade |
Research & Development | 14,665 | 17,232 | 15,085 | 14,135 | 14,277 | Upgrade |
Operating Expenses | 38,341 | 39,184 | 35,251 | 33,213 | 33,783 | Upgrade |
Operating Income | 25,596 | 22,601 | 23,864 | 22,181 | 21,555 | Upgrade |
Interest Expense | - | -755 | -772 | -276 | -183 | Upgrade |
Interest & Investment Income | 85 | 1,332 | 1,261 | 490 | 53 | Upgrade |
Currency Exchange Gain (Loss) | - | -214 | -366 | -286 | -216 | Upgrade |
Other Non Operating Income (Expenses) | 7,209 | 1,482 | 1,764 | -556 | -550 | Upgrade |
EBT Excluding Unusual Items | 32,890 | 24,446 | 25,751 | 21,553 | 20,659 | Upgrade |
Merger & Restructuring Charges | -228 | -1,469 | -1,098 | -575 | -209 | Upgrade |
Gain (Loss) on Sale of Investments | - | -300 | -600 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | 226 | 117 | 380 | 617 | Upgrade |
Asset Writedown | - | -405 | -1,295 | -1,216 | -989 | Upgrade |
Legal Settlements | - | -5,500 | -6,900 | - | - | Upgrade |
Other Unusual Items | - | -100 | -600 | - | - | Upgrade |
Pretax Income | 32,581 | 16,687 | 15,062 | 19,359 | 19,178 | Upgrade |
Income Tax Expense | 5,777 | 2,621 | 1,736 | 2,989 | 1,377 | Upgrade |
Earnings From Continuing Operations | 26,804 | 14,066 | 13,326 | 16,370 | 17,801 | Upgrade |
Earnings From Discontinued Operations | - | - | 21,827 | 1,571 | 3,077 | Upgrade |
Net Income | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 | Upgrade |
Net Income to Common | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 | Upgrade |
Net Income Growth | 90.56% | -59.99% | 95.94% | -14.07% | 41.89% | Upgrade |
Shares Outstanding (Basic) | 2,429 | 2,407 | 2,534 | 2,625 | 2,632 | Upgrade |
Shares Outstanding (Diluted) | 2,429 | 2,429 | 2,560 | 2,664 | 2,674 | Upgrade |
Shares Change (YoY) | - | -5.12% | -3.89% | -0.38% | 0.12% | Upgrade |
EPS (Basic) | 11.03 | 5.84 | 13.88 | 6.83 | 7.93 | Upgrade |
EPS (Diluted) | 11.03 | 5.79 | 13.72 | 6.73 | 7.81 | Upgrade |
EPS Growth | 90.50% | -57.81% | 103.94% | -13.84% | 41.75% | Upgrade |
Free Cash Flow | - | 19,842 | 18,248 | 17,185 | 19,758 | Upgrade |
Free Cash Flow Per Share | - | 8.17 | 7.13 | 6.45 | 7.39 | Upgrade |
Dividend Per Share | - | 4.910 | 4.700 | 4.450 | 4.190 | Upgrade |
Dividend Growth | - | 4.47% | 5.62% | 6.21% | 5.28% | Upgrade |
Gross Margin | 67.88% | 69.56% | 69.42% | 69.25% | 70.28% | Upgrade |
Operating Margin | 27.17% | 25.45% | 28.02% | 27.73% | 27.38% | Upgrade |
Profit Margin | 28.46% | 15.84% | 41.28% | 22.43% | 26.52% | Upgrade |
Free Cash Flow Margin | - | 22.34% | 21.43% | 21.48% | 25.09% | Upgrade |
EBITDA | 32,919 | 29,940 | 30,967 | 28,510 | 28,206 | Upgrade |
EBITDA Margin | 34.95% | 33.71% | 36.36% | 35.64% | 35.82% | Upgrade |
D&A For EBITDA | 7,323 | 7,339 | 7,103 | 6,329 | 6,651 | Upgrade |
EBIT | 25,596 | 22,601 | 23,864 | 22,181 | 21,555 | Upgrade |
EBIT Margin | 27.17% | 25.45% | 28.02% | 27.73% | 27.38% | Upgrade |
Effective Tax Rate | 17.73% | 15.71% | 11.53% | 15.44% | 7.18% | Upgrade |
Advertising Expenses | - | 600 | 500 | 700 | 1,200 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.